To further establish that inhibition of SHN3 may be an attractive target to promote bone formation as a therapy for osteoporosis, 3-month-old female mice lacking SHN3 (Shn3−/−) were subjected to ovariectomies, and bone mass was assessed by microCT 2 months post surgery. Here, HIVEP3 is linked to osteoporosis.